Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials
Study 304: ClinicalTrials.gov identifier, NCT02783729, date of registration, 26 May 2016. Study 106: ClinicalTrials.gov identifier, NCT02583451, date of registration, 22 October 2015. Study 108: ClinicalTrials.gov identifier, NCT03008447, date of registration, 2 January 2017.
Authors
- Sanford H. Auerbach (ORCID: https://orcid.org/0000-0003-2962-6405)
- Manoj Malhotra (ORCID: https://orcid.org/0000-0002-4315-8284)
- Kazuo Mishima (ORCID: https://orcid.org/0000-0003-1182-1181)
- Mark H. Gotfried (ORCID: https://orcid.org/0000-0001-7279-8101)
- Thien Thanh Dang‐Vu (ORCID: https://orcid.org/0000-0002-7235-2721)
- Margaret Moline (ORCID: https://orcid.org/0000-0003-0807-2167)
- Dinesh Kumar (ORCID: https://orcid.org/0000-0001-5880-4237)
Institutions
- Boston University (US)
- Akita University (JP)
- Pulmonary Associates (US)
- Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal (CA)
- Eisai (United States) (US)
- Eisai (Japan) (JP)
- Concordia University (CA)
Publication Details
- Journal
- Drugs & Aging
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1007/s40266-024-01135-8
- Citations
- 11
- Primary Topic
- Sleep and related disorders
- Type
- article
- Field-Weighted Citation Impact
- 5.58
Funders
- Eisai
- Eisai Incorporated